Bone Marrow Scintigraphy Using Technetium-99m-Antigranulocyte Antibody in Hematologic Disorders

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 978-982

  Chung, June Key ^a   Yeo, Jeongseok ^a   Lee, Dong Soo ^a   Park, Seonyang ^a   Lee, Myung Chul ^a   Kim, Byoung Kook ^a   Koh, Chang Soon ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Aplastic anemia; Bone marrow scintigraphy; Hematologic disorder; Myelodysplastic syndrome; Technetium 99m anti nca 95

Indexed keywords

DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; TECHNETIUM;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW; FEMALE; GRANULOCYTE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOLOGY; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; RADIOIMMUNOASSAY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTIBODIES, MONOCLONAL; BONE MARROW; FEMALE; GRANULOCYTES; HEMATOLOGIC DISEASES; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RADIOIMMUNODETECTION; TECHNETIUM;

EID: 0030161596     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fordham EW, Ali A. Radionuclide imaging of bone marrow. Semin Hematol 1981;18:222-239.
2. Padhy AK, Garg A, Kochupillai V, Gopinath PG, Basu AK. Marrow uptake index: a quantitative scintigraphic study of bone marrow in aplastic anemia. Thymus 1987;10:137-146.
3. Greenberg ML, Atkins HL, Schiffer LM. Erythropoietic and reticuloendothelial function in bone marrow in dogs. Science 1966;152:526-528.
4. Farrer PA, Saha GB, Kalz M. Further observation of the use of indium 111 -transferrin for the visualization of bone marrow in man. J Nucl Med 1973;14:394-395.
5. McNeil BJ, Holman BL, Button LN, et al. Use of indium-chloride scintigraphy in patients with myelofibrosis. J Nucl Med 1974;15:647-651.
6. Chaudhri TK, Ehrhardt JC, DeGowin RL, et al. Ferrous-59 whole-body scanning. J Nucl Med 1974;15:667-673.
7. Knospe WH, Rayudu GV, Cardello M, et al. Bone marrow scanning with iron-52. Regeneration and extension of marrow after ablative doses of radiotherapy. Cancer 1976;37:1432-1442.
8. 99mTc-labeled antibody for in vivo targeting of granulocyte. J Nucl Med 1988;29:925
9. 99mTc-labeled anti-NCA-95 monoclonal antibody. Nucl Med Biol 1995;22:117-123.
10. Reske SN, Karstens JH, Gloeckner MW, Schwarz A, Steinstraesser A, Ammon J, Buell U. Radioimmunoimaging of bone marrow. Results in patients with breast cancer and skeletal metastases and patients with malignant melanoma. Lancet 1989;2:299-301.
11. Duncker CM, Carrio I, Berna L, et al. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 1990;31:1450-1455.
12. 99mTc-MDP bone scan. Kor J Nucl Med 1994;28:89-97.
13. Lee J-H, Chung H-K, Kimm S-W. Purification of carcinoembryonic antigen from culture supernatant of human colon cancer cell line LS174T using monoclonal immunoaffinity chromatography. Kor J Biochem 1988;20:23-32.
14. Lilien DL, Berger HG, Anderson DP, et al. Indium-111-chloride: a new agent for bone marrow imaging. J Nucl Med 1973;14:184-186.
15. McNeil BJ, Rappeport JM, Nathan DG. Indium chloride scintigraphy: an index of severity in patients with aplastic anemia. Br J Haematol 1976;34:599-604.
16. Mishkin FS, Freeman LM. Miscellaneous applications of radionuclide imaging. In: Freeman LM. ed. Freeman and Johnson 's clinical radionuclide imaging. 3rd ed. Orlando: Grune & Stratton; 1984;1365-1460.
17. McIntyre RA, Larson SM, Scheffel U, et al. Comparisons of metabolism of iron-transferrin and indium-transferrin by erythropoietic marrow. J Nucl Med 1973;14:425-426.
18. Staub RF, Gorston E. Indium-111-chloride distribution kinetics in hematologic disease. J Nucl Med 1973;14:456-457.
19. 99mTc anti-NCA monoclonal antibodies for imaging inflammation. Eur J Nucl Med 1988;14:367-373.
20. Berna L, Germa JR, Estorch M, Torres G, Blanco R, Carrio I. Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma. J Nucl Med 1991;32:2295-2298.
21. Najean Y, Le Danvic M, Le Mercier N, Pecking A, Colonna P, Rain JD. Significance of bone marrow scintigraphy in aplastic anemia: concise communication. J Nucl Med 1980;21:213-218.
22. Sayle BA, Helmer III RE, Birdsong BA, Balachandran S, Gardner FH. Bone marrow imaging with indium-111-chloride in aplastic anemia and myelofibrosis: concise communication. J Nucl Med 1982;23:121-125.
23. Hotta T, Murate T, Inuoc C, et al. Patchy haemopoiesis in long-term remission of idiopathic aplastic anemia. Eur J Haematol 1990;45:73-77.
24. Gordon MY, Gordon-Simth EC. Bone marrow fibroblastoid colony-forming cells (F-CFC) in aplastic anemia: colony growth and stimulation of granulocyte-macrophage colony forming cells (GM-CFC). Br J Haematol 1981;49:465-477.
25. Reske SN. Recent advances in bone marrow scanning. Eur J Nucl Med 1991;18:203-221.
26. Tricot G, Do Wolf-Peeters C, Vlietinck R, et al. Bone marrow histology in myelodysplastic syndromes: II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol 1984;58:217-225.
27. Tricot G, Vlietinck R, Verwilghen RL. Prognostic factors in the myelodysplastic syndromes: a review. Scand J Haematol 1986;36 (suppl 45):107-113.
28. Locher JT, Seybold RY, Andres PA, Schubiger JP, Mach F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocyte antibodies. Nucl Med Commun 1986;7:659-670.
29. Seybold K, Locher JT, Coosemans C, et al. Immunoscintigraphic localization of inflammatory lesions: clinical experience. Eur J Nucl Med 1988;13:587-593